Patents by Inventor ADAM M. CHAKER

ADAM M. CHAKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ratio of immune cells as prognostic indicator of therapeutic success in allergen-specific immunotherapy
    Patent number: 11821894
    Abstract: The present invention relates to a ratio of immune cells for use in a method of predicting therapeutic success of an allergen-specific immunotherapy (AIT) in a patient suffering from or having a disposition to develop an allergic disease. Furthermore, the present invention also relates to a kit for predicting therapeutic success of an allergen-specific immunotherapy in a patient suffering from or having a disposition to develop an allergic disease. Furthermore, the present invention relates to a method of predicting therapeutic success of an allergen-specific immunotherapy (AIT) in a patient suffering from or having a disposition to develop an allergic disease.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: November 21, 2023
    Assignee: KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITÄT MÜNCHEN
    Inventors: Carsten B. Schmidt-Weber, Adam M. Chaker, Ulrich M. Zissler, Constanze A. Jakwerth
  • A RATIO OF IMMUNE CELLS AS PROGNOSTIC INDICATOR OF THERAPEUTIC SUCCESS IN ALLERGEN-SPECIFIC IMMUNOTHERAPY
    Publication number: 20210333264
    Abstract: The present invention relates to a ratio of immune cells for use in a method of predicting therapeutic success of an allergen-specific immunotherapy (AIT) in a patient suffering from or having a disposition to develop an allergic disease. Furthermore, the present invention also relates to a kit for predicting therapeutic success of an allergen-specific immunotherapy in a patient suffering from or having a disposition to develop an allergic disease. Furthermore, the present invention relates to a method of predicting therapeutic success of an allergen-specific immunotherapy (AIT) in a patient suffering from or having a disposition to develop an allergic disease.
    Type: Application
    Filed: June 21, 2018
    Publication date: October 28, 2021
    Inventors: CARSTEN B. SCHMIDT-WEBER, ADAM M. CHAKER, ULRICH M. ZISSLER, CONSTANZE A. JAKWERTH